Posted on February 11, 20262/11/26
Inside the Shifting Role of Pharma 3PLs: Resilient, Regulated & Ready
Posted on February 11, 20262/11/26
EVERSANA Recognized by Vault for the Fifth Consecutive Year
Posted on February 10, 20262/10/26
Rewiring Commercialization for Biotech’s New Reality
Posted on February 3, 20262/3/26
How Pharma Marketers Can Prepare for the Next Wave of Healthcare AI
Posted on January 30, 20261/30/26
Bringing a Breakthrough Rare Disease Therapy to Market with Rapid Speed for Patients
Posted on January 23, 20261/23/26
Putting Data Science in the Spotlight
Posted on January 14, 20261/14/26
NAVLIN Daily 2025 Round-Up: The Pricing and Policy Trends Redefining Market Access
Posted on December 30, 202512/30/25
How Pharma and PBMs Can Coexist and Lower Drug Costs Faster
Posted on December 26, 202512/26/25